FB pixel

Imprivata’s new patient identification platform uses palm vein biometrics


Imprivata launched Imprivata PatientSecure, a palm vein biometrics-based patient identification solution that generates a one-to-one link between patients and their correct medical record in their healthcare provider’s electronic health record (EHR) system.

Imprivata PatientSecure helps resolve the growing need to accurately identify patients by scanning the patient’s hand to capture their unique palm vein pattern, which ultimately matches patients with their digital health record.

The solution directly integrates with the top healthcare information systems and helps improve patient safety and satisfaction, prevent duplicate medical records and overlays, drive revenue cycle efficiency, and protect against identity theft and insurance fraud.

“Patient misidentification is fast becoming one of the biggest challenges facing care delivery organizations as they grapple with the growing need to combat increased attempts at identity theft and insurance fraud while also trying to reduce duplicate medical records and patient identification mistakes,” said David Wiener, general manager, Imprivata PatientSecure Products Group. “As our healthcare system continues to digitize, enabling care delivery organizations to leverage a simple and secure identification platform is critical to enhancing the patient experience and addressing the growing medical identity theft and insurance fraud nationally.”

Imprivata PatientSecure is designed to simplify the often-tedious patient enrollment, check-in, and registration process, while providing patients with security and protection of their privacy.

The solution’s palm vein scanner is unintrusive to patients, which makes it the ideal method of identification at any point in the care process.

When the solution is deployed in concert with a self-service kiosk solution, Imprivata PatientSecure further cuts wait times and improves patient satisfaction measures such as HCAHPS scores that influence hospital’s Meaningful Use targets.

Previously reported, Tractica published a new report entitled “Biometrics in the Healthcare Industry”, which provides a 10-year forecasts for the period from 2015 through 2024 in which the worldwide healthcare biometrics market will reach a cumulative revenue of $12.5 billion by 2024.

Article Topics

 |   |   |   |   |   | 

Latest Biometrics News


6 Replies to “Imprivata’s new patient identification platform uses palm vein biometrics”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Read This Week

Featured Company

Biometrics Research

Biometrics White Papers

Biometrics Events

Explaining Biometrics